PERSPECTA

News from every angle

← Back to headlines

Summit Therapeutics Reports Q4 Earnings, Missing EPS Estimates

Summit Therapeutics announced its fourth-quarter financial results, with Non-GAAP EPS of -$0.14, missing estimates by $0.12.

23 Feb, 21:40 — 23 Feb, 21:40
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

seeking-alpha3h ago

Summit Therapeutics Non-GAAP EPS of -$0.14 misses by $0.12

Read full article →

Related Stories

FDA Flags Major Philippine Retailers for Unregistered Products

just now

Why Monday market’s not picking up in S-East — Traders

7m ago

Panama Cancels CK Hutchison Contracts, Temporarily Hands Canal Ports to Maersk

8m ago

Adeia Outlines 2026 Revenue Guidance, Pay-TV Share Projected to Fall

11m ago